Innovative Cancer Drugs Get Funding In Australian Govt’s Pre-Election Budget
Executive Summary
This week's budget in Australia includes extra funding for the reimbursement of some key new cancer drugs under the Pharmaceutical Benefits Scheme, as well as more money for clinical trials of drugs for rare diseases.
You may also be interested in...
Australian Drug Industry Lays Out Wishlist As Elections Near
With the government and opposition parties in Australia in full pre-election promise mode, the pharmaceutical industry has called on the future government to guarantee the sustainability of the drug reimbursement system, extend the data exclusivity period and review the National Medicines Policy on access to new drugs.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.